Coronavirus Pandemic Exposure to COVID-19 among unvaccinated healthcare personnel and risk for infection: a single-center retrospective study

Introduction: Characteristics of exposure and infection risk, are important in strategy development for infection control among healthcare workers (HCWs). Our objective was to investigate the characteristics of exposure of HCWs to SARS-CoV-2 and determine the risk of COVID-19 development. Methodology: This is a retrospective single-center cohort study, conducted between March and December 2020. Unvaccinated and exposed HCWs were asked to complete a standard form, including demographic data and characteristics of exposure(s). Exposures were stratified according to national guidelines. STROBE checklist was used. Results: Among a total of 4,385 healthcare workers, 1,483 HCWs (33.8%) with a total of 1,903 exposures to SARS-CoV-2 were identified. Median age was 31 (IQR: 26-40) years and 45.4% were male (N = 673). Following exposure, 78 HCWs became SARS-CoV-2-positive (attack rate: 3.9%) and secondary attack rate was 4/16. In terms of infection, exposure to SARS-CoV-2-positive HCWs posed a greater risk compared to contact with patients (8.9%, [n = 66] vs. 3.8% [n = 12], respectively, p = 0.003). PCR positivity rates were 11.5%, 6.3%, and 8.4% for low, medium, and high-risk contacts ( p = 0.152). Median time to infection post-exposure was 7 (IQR: 4-13) days. Conclusions: Given the attack rates, there was no correlation between risk levels and PCR test positivity rates. There was no difference between HCWs with or without work restrictions, in terms of PCR positivity. Due to feasibility issues, prioritizing universally applied symptom screening and resource control strategies and suspending contact tracing and work restrictions, appear to be safe during high prevalence period.

[1]  R. Hussein,et al.  SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital , 2021, PloS one.

[2]  C. Coltart,et al.  National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates , 2021, BMJ Open.

[3]  V. Borja-Aburto,et al.  Infection and death by COVID-19 in a cohort of healthcare workers in Mexico , 2021, Scandinavian journal of work, environment & health.

[4]  B. Unal,et al.  Transmission dynamics and timing of key events for SARS-CoV-2 infection in healthcare workers , 2021, Infectious diseases.

[5]  B. Goudra,et al.  An Overview of Health Care Worker Reported Deaths During the COVID-19 Pandemic. , 2021, Journal of the American Board of Family Medicine : JABFM.

[6]  X. Huo,et al.  Secondary attack rates of COVID-19 in diverse contact settings, a meta-analysis. , 2020, Journal of infection in developing countries.

[7]  Kevin Y. Du,et al.  Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age , 2020, Journal of Ovarian Research.

[8]  M. Jorge Cardoso,et al.  Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study , 2020, The Lancet Public Health.

[9]  R. Hod,et al.  COVID-19 among Health Workers in Germany and Malaysia , 2020, International journal of environmental research and public health.

[10]  A. Kenarkoohi,et al.  Sex and gender differences in the outcome of patients with COVID‐19 , 2020, Journal of medical virology.

[11]  P. Lapolla,et al.  Deaths from COVID-19 in healthcare workers in Italy—What can we learn? , 2020, Infection Control & Hospital Epidemiology.

[12]  C. Reiss Coronavirus Pandemic. , 2020, DNA and cell biology.

[13]  Gholamreza Farnoosh,et al.  Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study , 2020, Journal of Clinical Virology.

[14]  Mingkun Zhan,et al.  Death from Covid-19 of 23 Health Care Workers in China , 2020, The New England journal of medicine.

[15]  Haibo Xu,et al.  Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China , 2020, Critical Care.

[16]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[17]  Jian-min Jin,et al.  Gender Differences in Patients With COVID-19: Focus on Severity and Mortality , 2020, Frontiers in Public Health.

[18]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[19]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[20]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[21]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[22]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[23]  Contact tracing: public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union, third update , 2020 .

[24]  P. Behera,et al.  SARS-CoV-2 epidemic in India: epidemiological features and in silico analysis of the effect of interventions. , 2020, F1000Research.